A momentous progress update: epidermal growth factor receptor inhibitors as viable agents for combating cancer

The study summarizes the findings from the last eight years of research on heterocyclic core-based epidermal growth factor receptor inhibitors. This provides an invaluable tool for oncology drug discovery.